Literature DB >> 26626785

Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations.

Anna De Rosa1, Teresa Pellegrino2, Sabina Pappatà2, Maria Teresa Pellecchia3, Silvio Peluso4, Francesco Saccà4, Paolo Barone3, Alberto Cuocolo5, Giuseppe De Michele4,2.   

Abstract

BACKGROUND: PARK2 is an autosomal recessive parkinsonism caused by parkin gene mutations. Several Parkinson's Disease (PD) cases harbor single parkin mutations, raising a debate about the pathogenic meaning of heterozygous mutations. Here, we evaluate cardiac autonomic innervation in patients with either two or one parkin mutations compared to patients with idiopathic PD (IPD). PATIENTS AND METHODS: Myocardial 123I-metaiodobenzylguanidine (MIBG) scintigraphy was performed in six PD patients with single parkin mutations (HET), four with two mutations (PARK2), and eight with IPD.
RESULTS: In comparison to control group, IPD patients showed lower early and late heart-to-mediastinum (H/M) ratios and higher washout rates, whereas HET patients had only lower early H/M ratio, and PARK2 patients were not different for any parameter. At individual level, MIBG findings were abnormal in 7/8 IPD, in 4/6 HET and in 1/4 PARK2 patients.
CONCLUSIONS: Preserved cardiac 123I-MIBG uptake confirms that PARK2 pathogenic mechanism, at least partially, differs from that responsible for IPD. HET subjects show intermediate findings, suggesting possible heterogeneity.

Entities:  

Keywords:  123I-metaiodobenzylguanidine myocardial scintigraphy; Parkinson’s Disease; parkin gene

Mesh:

Substances:

Year:  2015        PMID: 26626785     DOI: 10.1007/s12350-015-0332-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  18 in total

1.  Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein.

Authors:  Blas Morales; Armando Martínez; Isabel Gonzalo; Lidice Vidal; Raquel Ros; Estrella Gomez-Tortosa; Alberto Rabano; Israel Ampuero; Marina Sánchez; Janet Hoenicka; Justo García De Yébenes
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

2.  Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies.

Authors:  Kenichi Kashihara; Manabu Ohno; Sanami Kawada; Yoshihiro Okumura
Journal:  J Nucl Med       Date:  2006-07       Impact factor: 10.057

3.  Neurophysiological evidence of corticospinal tract abnormality in patients with Parkin mutations.

Authors:  Anna De Rosa; Giampiero Volpe; Lucia Marcantonio; Lucio Santoro; Alexis Brice; Alessandro Filla; Anna Perretti; Giuseppe De Michele
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

Review 4.  The neuropathology of genetic Parkinson's disease.

Authors:  Markos Poulopoulos; Oren A Levy; Roy N Alcalay
Journal:  Mov Disord       Date:  2012-03-26       Impact factor: 10.338

5.  Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure.

Authors:  Teresa Pellegrino; Mario Petretta; Serena De Luca; Stefania Paolillo; Antonio Boemio; Raffaella Carotenuto; Maria Piera Petretta; Carmine di Nuzzo; Pasquale Perrone-Filardi; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-06       Impact factor: 9.236

6.  The parkin gene and its phenotype. Italian PD Genetics Study Group, French PD Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.

Authors:  V Bonifati; G De Michele; C B Lücking; A Dürr; E Fabrizio; G Ambrosio; N Vanacore; M De Mari; R Marconi; L Capus; M M Breteler; T Gasser; B Oostra; N Wood; Y Agid; A Filla; G Meco; A Brice
Journal:  Neurol Sci       Date:  2001-02       Impact factor: 3.307

7.  Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report.

Authors:  Masahiko Suzuki; Nobutaka Hattori; Satoshi Orimo; Nobuyoshi Fukumitsu; Masahiro Abo; Yu Kono; Renpei Sengoku; Akira Kurita; Hidehiko Honda; Kiyoharu Inoue
Journal:  Mov Disord       Date:  2005-05       Impact factor: 10.338

8.  Lewy body pathology in a patient with a homozygous parkin deletion.

Authors:  Saori Miyakawa; Mieko Ogino; Sayaka Funabe; Akiko Uchino; Yasushi Shimo; Nobutaka Hattori; Masaaki Ichinoe; Tetuo Mikami; Makoto Saegusa; Kazutoshi Nishiyama; Hideo Mori; Yoshikuni Mizuno; Shigeo Murayama; Hideki Mochizuki
Journal:  Mov Disord       Date:  2013-02-11       Impact factor: 10.338

9.  Complex relationship between Parkin mutations and Parkinson disease.

Authors:  Andrew West; Magali Periquet; Sarah Lincoln; Christoph B Lücking; David Nicholl; Vincenzo Bonifati; Nina Rawal; Thomas Gasser; Ebba Lohmann; Jean-François Deleuze; Demetrius Maraganore; Allan Levey; Nick Wood; Alexandra Dürr; John Hardy; Alexis Brice; Matt Farrer
Journal:  Am J Med Genet       Date:  2002-07-08

10.  Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation.

Authors:  Madeleine E Sharp; Karen S Marder; Lucien Côté; Lorraine N Clark; William C Nichols; Jean-Paul Vonsattel; Roy N Alcalay
Journal:  Mov Disord       Date:  2013-12-27       Impact factor: 10.338

View more
  3 in total

Review 1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-11-08       Impact factor: 5.952

2.  Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington's disease.

Authors:  Roberta Assante; Elena Salvatore; Carmela Nappi; Silvio Peluso; Giovanni De Simini; Luigi Di Maio; Gianluigi Rosario Palmieri; Isabella Pia Ferrara; Alessandro Roca; Giuseppe De Michele; Alberto Cuocolo; Sabina Pappatà; Anna De Rosa
Journal:  J Nucl Cardiol       Date:  2020-08-16       Impact factor: 5.952

3.  α-Synuclein Deposition in Sympathetic Nerve Fibers in Genetic Forms of Parkinson's Disease.

Authors:  Risa Isonaka; David S Goldstein; William Zhu; Esther Yoon; Debra Ehrlich; Alice B Schindler; Angela D Kokkinis; Marya S Sabir; Sonja W Scholz; Sara Bandres-Ciga; Cornelis Blauwendraat; Pedro Gonzalez-Alegre; Grisel Lopez; Ellen Sidransky; Derek P Narendra
Journal:  Mov Disord       Date:  2021-06-02       Impact factor: 9.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.